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Abstract (250 words) 
Purpose 
Glaucoma is a leading cause of blindness in people of African descent. Minimal data is 
available from African population-based cohort studies. The primary aims of this study 
were to describe the normative distribution of glaucoma features to enable glaucoma 
classification and to assess risk factors for those with glaucoma at follow-up among 
people aged ≥50 years in Kenya. 
 
Materials and Methods 
Random cluster sampling with probability proportionate to size was used to select a 
representative cross-sectional sample of adults aged ≥50 years in 2007-8 in Nakuru 
District, Kenya. A six-year follow-up was undertaken in 2013-14. Comprehensive 
ophthalmic examination included visual acuity, digital retinal photography, visual fields, 
intra-ocular pressure, OCT and independent grading of optic nerve images. We 
report glaucoma features, prevalence and predictors for glaucoma based on the 
ISGEO criteria. Measures were estimated using a Poisson regression model and 
including inverse-probability weighting for loss to follow up.  
 
Results 
At baseline, 4,414 participants aged ≥50 years underwent examination. Anterior 
chamber OCT findings: mean anterior chamber angle of 36.6°, mean central corneal 
thickness of 508.1µm and a mean anterior chamber depth of 2.67mm. 2,171 
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participants were examined at follow-up. The VCDR distribution was 0.7 and 0.8 at 
the 97.5th and 99.5th percentiles, respectively. A total of 88 (4.3%, 95% CI, 3.5-5.9%) 
of participants at follow-up had glaucoma consistent with ISGEO criteria. A RAPD and 
raised IOP were associated with the diagnosis.  
Conclusions 
Glaucoma is a public health challenge in low-resource settings. Research into testing 
and treatment modalities in Africa is needed. 
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Introduction 
Glaucoma is a leading cause of blindness globally.1 The proportion of the worldwide 
magnitude of blindness attributable to glaucoma increased by 50% between 1990 and 
2010 from 4.4% to 6.6%.2 This trend is expected to continue over coming decades, 
with the estimated numbers with glaucoma predicted to rise from 60.5 million people 
in 2010 to 79.6 million by the year 2020 3 and then to 111.8 million by 2040.4 Glaucoma 
is the second most common cause of blindness in sub-Saharan Africa (SSA),5 with 
estimates suggesting that there were 6.5 million people with glaucoma in SSA in 2010 
projected to increase to 8.4 million by 2020, though data are sparse.6 
Whilst blindness from glaucoma may be preventable, this is dependent upon early 
diagnosis and delivery of long-term effective treatment. Glaucoma poses a particular 
problem in sub-Saharan Africa due to both higher age-specific prevalence, higher risk 
for open-angle glaucoma,7-10, late presentation11 and low levels of coverage and 
adherence with treatment.12, 13 Adherence to topical treatment is sufficiently poor that 
the primary treatment of choice in SSA is often surgery5 in the hope that a single 
intervention achieves long term control of intra-ocular pressure (IOP) as the main 
modifiable risk factor. 11-13 Furthermore, clinical features of glaucoma may be different 
in a sub-Saharan African setting compared to elsewhere, necessitating different 
therapeutic approaches. 
The objectives of this study were, within the context of a population-based cohort 
study in Nakuru, Kenya: i) to describe normative features of glaucoma in this cohort, 
ii), to describe the prevalence of glaucoma or specific glaucoma features at baseline 
and at follow up, iii) to assess baseline risk factors for having glaucoma at follow up 
and iv) to describe clinical signs predictive of glaucoma at follow up. 14 The distribution 
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of key features of glaucoma (optic nerve morphology, intraocular pressure, visual 
acuity, angle morphology) and the risk factors associated with changing optic disc 
morphology that occurred over the six year follow up period will also be described.  
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Materials and Methods 
Ethics Statement 
The London School of Hygiene & Tropical Medicine (LSHTM) Ethics committee and 
the African Medical Research Foundation (AMREF) granted ethical approval for the 
study. Approval was also granted by the Provincial Medical Officer for Nakuru County. 
Written approval was sought from the administrative heads in each cluster, usually 
the village chief. All participants gave written or thumbprint consent to participate. 
People requiring medical treatments were referred to the appropriate health care 
service. 
 
Sampling Strategy and Recruitment 
The study baseline fieldwork was carried out between January 2007 and November 
2008. The follow-up study took place between October 2012 and March 2014. At 
baseline, 100 clusters were selected across Nakuru County with a probability 
proportional to the size of the population using the electoral roll as the sampling 
frame. A cluster was defined as the area served by a polling station. Households were 
selected within clusters using a modified compact segment sampling method 15. Each 
cluster was divided into segments so that each segment included approximately 50 
people aged ≥50 years. One segment was selected at random, and all eligible people 
were included sequentially until 50 had been examined.  
The sample size of 5000 people was sufficient to estimate a prevalence of disease at 
3.0% among those aged ≥50 years, with a required precision of 0.5%, 95% confidence, 
a design effect to account for clustering of 1.5, and a response rate of 90% (Epi Info 
6.04, Centers for Disease Control and Prevention, Atlanta, GA). In total, 4,381 
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participants were recruited at baseline (response rate 81%). All participants were 
invited to attend an examination clinic at a central location within the cluster (see 
below). 
 
Follow-up 
Approximately one week before the follow-up examination clinic was carried out for 
a given cluster, a field officer studied the maps of the village including GPS coordinates 
recorded at baseline and made phone contact with the village chief or guide to arrange 
the visit. At the planning visit a list of study participants were given to the chief and a 
local village guide was recruited to assist locating the study participants. Two days 
prior to the clinic, the field officer reminded chiefs of the visit by phone and notified 
them and the guide of the advance team’s arrival. On the day prior to the examination 
clinic, a study team visited homes of baseline participants and confirmed their identity 
using National Identity cards and invited them to attend the examination clinic the 
following day.  All identified participants were also asked to help locate baseline 
participants that had not been found. 
On the examination day, the advance team confirmed the identity of participants 
against data from baseline (age, date of birth, name, and identity cards). In cases of 
uncertain identity, confirmation was made based on retinal examination verified by 
comparison of retinal photos with baseline photo (n=12). 
In both baseline and follow-up, an examination clinic was established at a central 
location where there were appropriate amenities such as electricity, water and road 
access. The following examination protocols were implemented at both baseline and 
follow-up. 14, 16 
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Ophthalmic and General Examination 
 
Visual Acuity 
All participants at baseline and follow-up underwent visual acuity testing on each eye 
separately at four meters using a reduced LogMAR tumbling ‘E’ chart17 in an 
appropriately illuminated area, as described elsewhere.18, 19 The presenting visual 
acuity was defined as the number of letters read correctly without glasses if the 
participant did not have glasses, or with glasses if they had them. 
 
Anterior Segment Examination 
At baseline the anterior segment assessment was made on the slit lamp by a single 
ophthalmologist (WM). The Van Herick angle assessment was performed. 20  
 
Anterior Chamber OCT 
Gonioscopic assessment of the angle was not undertaken, however a Heidelberg Slit 
Lamp-adapted Optical Coherence Tomography (SL-OCT) (Heidelberg Engineering, 
Heidelberg, Germany) was used at baseline to examine the anterior segment to 
provide population normative data on the Angle Opening Distance (AOD), Anterior 
Chamber Angle (ACA), Central Corneal Thickness (CCT) and Anterior Chamber 
Depth (ACD). These normative data analyses excluded eyes that were pseudophakic. 
Furthermore, eyes with trachomatous or non-trachomatous corneal opacities and 
those with disorganized globes (phthisis, staphyloma) were excluded from the corneal 
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thickness analysis. All measurements were obtained from scans using the interactive 
distance measurement of the SL-OCT proprietary software (Heidelberg Eye Explorer 
v1.5.9.0; Heidelberg Engineering, Heidelberg, Germany). Analyses based on naso-
temporal (horizontal) meridians. Anterior chamber depth was assessed using peaks of 
the corneal reflectivity profile to identify the central cornea as well as the anterior 
and posterior boundaries of the cornea. Calipers were aligned from the posterior 
border of the central cornea. Two measurements were averaged for each eye. 
Anterior chamber angle opening distance was taken as posterior cornea and opposite 
peripheral iris with the apex lying in the angle recess.  All anterior segment 
measurements were taken with the pupil undilated.  
 
Gonioscopy 
At follow-up, an assessment of the opening angle of participants’ right and left eyes 
using direct visualisation was made using a four-mirror gonioscopy lens (Zabbys).  This 
lens does not require coupling fluid and was chosen to minimize impact on the quality 
of retinal photographs. Angles were recorded using standard Shaffer grading and 
further classified as “open”, “occludable” or “closed” based on standard referral 
criteria. 21 Angle OCT was not performed at follow-up. Occludable angles were 
defined at follow up as: pigmented trabecular meshwork not visible in 3⁄4 or more of 
angle circumference in primary position without manipulation, in presence of low 
illumination. If the patient could not cooperate with gonioscopy, the Van Herick (VH) 
technique 20 was used for grading with an anterior chamber depth of less than quarter 
of the corneal thickness being considered occludable.  
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Intraocular Pressure (IOP) 
At baseline and follow-up participant’s eyes were anesthetized using tetracaine 1% eye 
drops (Kenya Society for the Blind, Eye Drop Production Unit, Nairobi, Kenya) and 
the tear film stained with fluorescein-impregnated paper. IOP was measured using a 
Goldmann Applanation Tonometer. One reading was taken from each eye and 
analysed independently. The tonometer was checked for calibration weekly and 
disinfected between patients. 
 
Visual Field Assessment  
At baseline, all individuals with suspect or abnormal discs on clinical slit-lamp 
examination underwent automated visual field testing. The Humphrey® Field Analyzer 
II - 720i series (Carl Zeiss Ophthalmic Systems, Oberkochen, Germany) was used. A 
suspect or abnormal disc was defined as a vertical cup to disc ratio (VCDR) of 0.7 or 
above; optic disc cupping asymmetry between the eyes of more than 0.2 VCDR; or 
any other abnormal features including notching, disc haemorrhages or disc pallor. A 
random sample of five individuals per cluster (10%) also underwent visual field testing 
to provide normative data.  
Participants performed the Swedish Interactive Thresholding Algorithm (SITA) 
STANDARD 24-2. SITA Fast was used to determine the threshold level in all 
participants having visual field analysis. Appropriate corrective lenses for refractive 
errors were used when needed. An automated fixation monitor was used throughout. 
If the SITA fast test was reliable the SITA standard test was performed. If the SITA 
fast was unreliable (false-positives, ≥20%; false-negatives, ≥33%; fixation losses, ≥33%), 
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then this was repeated once. If it remained unreliable then no further testing was 
done. 
 
At follow-up, a different strategy for visual field testing was used due to challenges at 
baseline: All subject’s eyes with VA equivalent to >=6/60 Snellen underwent 
automated visual field testing by a trained visual field technician using the Henson 8000 
Visual Field Analyser (TopCon, Tokyo, Japan) The multiple stimulus suprathreshold 
test was used following manufacturers guidelines (Screening test - 26 test locations). 
When one or more spots were missed, the 26-point test was repeated for that eye. 
If any missed spots re-occurred on the second time of testing the test for that eye 
was extended to 68 test locations. This machine and strategy were used in preference 
to the baseline methods due to feedback from both patient’s and tester at baseline as 
well as unreliable visual field data from baseline. Patient’s found the baseline testing 
protocol difficult to understand and the time required to complete the test meant 
only a sub-sample of the population could be investigated. 
 
Visual fields were considered consistent with glaucoma at baseline and follow-up if: 
(1) The test was reliable according to performance indices 
(2) The glaucoma hemifield test was outside normal limits, and 
(3) The test showed three or more abnormal contiguous points clustering in the same 
hemi field.   
Visual Fields were graded at the Moorfields Eye Hospital Reading Centre.  
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Fundus photography and grading 
The participants had two non-stereoscopic digital 45o fundus photographs taken per 
eye by an ophthalmic clinical officer using a TRC-NW6S Non-Mydriatic Retinal 
Camera with 10 megapixel Nikon D80 (TopCon, Tokyo, Japan) at baseline and a DRS 
CentreVue+ (Haag-Streit, Köniz, Switzerland) Retinal Camera at follow-up. One 
image was centered on the optic disc while the other was centered on the macula.  
The digital images were forwarded to the Retinal Grading Centre at Moorfields Eye 
Hospital Reading Centre (MEHRC) London for grading and confirming the clinical 
diagnosis of posterior segment disease.  
The senior grader graded all discs considered abnormal on clinical examination at the 
slitlamp at baseline and all optic nerve images at follow-up. Images were first 
categorized for quality as excellent, good, fair, borderline or ungradeable. They were 
then graded for vertical cup disc ratio (VCDR). The scleral ring was identified to 
determine the margins of the disc and delineating the rim identified the cup. The rim 
was defined as the area between the border of the optic disc and the position of blood 
vessel bending and the area within the rim as the cup. A vertical measure of both the 
cup and disc were taken to calculate the VCDR. Discs images were also examined for 
any abnormality and were graded as normal, suspicious or abnormal. A disc was 
deemed abnormal if any of neuro-retinal rim (NRR) thinning, notching or disc 
hemorrhage(s) were present, if VCDR was ≥0.7. A suspicious disc was one where 
adjudication was necessary to determine if its appearance was abnormal. 
In case of difficulties, the adjudicator (TP) decided on the grading of the images. The 
adjudicator also graded 5% of randomly selected images to ensure quality control.  
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At baseline and follow-up, all participants’ discs were estimated based on image 
grading.  
 
Data Handling & Statistical Analyses Methods 
Data entry 
Image data were double entered into a specially developed dataset (EpiData Entry v 
2.1) at both baseline and follow up. Consistency checks were performed each evening 
and inconsistencies corrected the same day.  
Data analysis 
The International Society for Geographical & Epidemiological Ophthalmology (ISGEO) 
categorises glaucoma as Primary Open Angle Glaucoma (POAG) and Primary Angle 
Closure (PAC) based on direct viewing of the angle. POAG is defined in three 
categories based on the optic nerve VCDR, visual fields, IOP, VA and the presence or 
absence of previous glaucoma surgery (clinically or from medical records). 22 The 
mean, 97.5th and 99.5th percentiles were calculated for optic disc VCDR and IOP for 
the participants at follow-up. Based on baseline normative data, the cut-off points 
required for ISGEO POAG classifications were used to classify accordingly: 22 
 Category 1 with structural and functional evidence: Eyes with a VCDR 
or VCDR asymmetry ≥97.5% for the normal population that showed a definite 
visual field defect consistent with glaucoma. 
 Category 2 (advanced structural damage with unproven field loss): 
Eyes of those without any or with no valid visual field testing but with a VCDR 
or asymmetry ≥99.5th percentile for the normal population. 
 15 
 Category 3 (no view of optic disc and field testing impossible): Eyes 
of those with VA<3/60 and the IOP>99.5th percentile, or VA<3/60 and 
evidence of glaucoma filtering surgery, or previous diagnosis of glaucoma 
confirmed from medical records. 
Glaucoma suspects were defined as: 
- field suspects: those with abnormal visual fields consistent with glaucomatous 
changes but no raised IOP, disc damage or features consistent with trabecular 
obstruction,  
- disc suspects: those with VCDR ≥97.5th percentile for the population but less 
than the 99.5th percentile and no other feature of glaucoma and no 
documented field defect. It also included those with optic disc hemorrhages 
accompanied by no other feature of glaucoma  
- Ocular Hypertensives: IOP ≥97.5th percentile with normal optic disc and normal 
visual field 
 
A normative sample was used to calculate the 97.5th and 99.5th percentiles of VCDR 
and IOP from those participants examined at follow-up with normal visual fields. 
 
Baseline to follow-up changes 
It was not possible to produce an annual glaucoma incidence due to the lack of reliable 
visual field data and therefore it was not possible to define an “at-risk” baseline group. 
Individuals at follow-up were classified as suspect or definite glaucoma -based on 
ISGEO criteria using graded images of the optic disc and visual fields. Participants at 
follow-up were then classified in a binary manner as normal or glaucoma (glaucoma if 
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ISGEO categories 1, 2 or 3 were fulfilled for that participant). Multivariable logistic 
regression analyses were conducted to compare those with and without features of 
glaucoma at follow-up in terms of baseline demographic, anthropometric and ocular 
features as potential risk factors of glaucoma.   
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Results 
Follow up rates 
At baseline (2007-2008), 4,414 participants had a complete assessment and of these, 
2,171 (50%) were seen at follow-up six years later. Characteristics of participants and 
non-participants at follow-up are described in detail elsewhere.23, 24 In summary, 
compared with those followed-up, participants who had died during follow-up were 
older, more likely to be male, to have lower education levels and higher systolic blood 
pressure and have diabetes, but had lower BMI. Compared with participants seen, 
those lost to follow-up (not known to be deceased) were less likely to be Kikuyu or 
Kalenjin speakers, had lower levels of education, and were more likely to be from 
urban areas and be from either the highest or lowest socioeconomic quartile.  
 
Anterior Chamber OCT 
Anterior segment findings at baseline using OCT are described in Table 1, the mean 
angle opening distance (n=6,259) was 631µm (SD:167), the mean anterior chamber 
angle (n=3,484) was 36.6° (SD:7.6), the mean central corneal thickness (n=6,365) was 
508.1 µm (SD:36.9), and the  mean anterior chamber depth (n=6,358) was 2.67mm 
(SD:0.32) 
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Gonioscopy 
Anterior Segment OCT was not available at follow-up, however 2,111 right eyes and 
2,107 left eyes had a direct visualisation of the angle using a 4-mirror gonioscope, with 
only five right and five left eyes (0.2%) considered to have occludable angles (based on 
visualisation of Schwalbe’s line and the anterior meshwork or less); see Table 2. 
 
 
 
 
 
 
Intraocular Pressure 
The mean IOP at baseline based on 3,745 observations (right eye only) was 15.3mmHg 
(SD 3.4, Range 2-46mmHg). Of these, there were 1,775 observations (right eyes only) 
for whom IOP was measured at both baseline and follow-up. Among these, at baseline 
mean IOP was 15.4 (SD 3.4) for the right eye, and at follow-up (right eyes) was 
15.0mmHg (SD 3.2, Range = 1-34mmHg), providing evidence of a lower IOP at follow 
up compared to baseline among right eyes (p<0.001). IOP was significantly higher in 
the right eye than the left eye at both baseline (p<0.001) and follow-up (p=0.02). See 
Table 3. 
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Optic discs 
At baseline, due to camera failure preventing image acquisition in one third of clusters, 
a slit lamp based clinical assessment of the optic disc vertical cup to disc ratio (VCDR) 
was made in two ways:  
1. Through undilated pupils with +90D lenses using slit lamp biomicroscopy 
(n=5,917 eyes) 
2. After dilating pupils with +90D lenses using slit lamp biomicroscopy (n=7,821 
eyes) 
 
Baseline optic disc assessment is summarised in Table 4.1,063 (25.7%) Right Eye discs 
and 1,078 (25.8%) Left Eye Discs could not be visualised with undilated pupils. There 
was a statistically significant difference between the mean VCDR for eyes with pupils 
dilated and non-dilated pupils where the disc was visible in both instances, with the 
dilated eyes having higher VCDR ratios (0.23, SD 0.15) than non-dilated eyes (0.21, 
SD 0.13) (paired t test<0.001). Using undilated CDR 1.5% of eyes had CDR≥0.7 while 
using dilated CDR, 2.8% of eyes had VCDR≥0.7 (X2=13.8 p=0.002). 
 
At follow up, the VCDR for right and left eyes from image grading were available in 
all clusters from 3,658 of a possible 4,342 eyes (2,171 people). The median VCDR was 
0.3 and at the 97.5th and 99.5th percentile it was 0.7 and 0.8 respectively. See Figure 1. 
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The VCDR percentiles at follow-up in those with a normal visual field (n=1062) 
remained at 0.7 and 0.8 at the 97.5th and 99.5th percentiles respectively.  
 
At baseline, 3,251 participants had a clinical assessment (i.e. no image grading) of the 
optic discs, of which 40 (1.2%) were considered abnormal, 536 (16.5%) suspicious and 
2,675 (82.3%) normal. At follow-up, 2,003 participants had an image-based assessment 
of the optic discs, of which 64 (3.2%) were graded as abnormal, 234 (11.7%) suspicious 
and 1,705 (85.1%) were normal. 89 of 1,255 (7.1%) participants who had a baseline 
(clinical) and follow-up (image) assessment went from “normal” to either “suspicious” 
or “abnormal”. Of the 1,499 participants who had optic discs graded at both baseline 
(clinical) and follow-up (image) 17l (1.1%) were considered abnormal, 236 (15.7%) 
suspicious and 1246 (83.1%) as normal at baseline. At follow up there were 53 (3.5%) 
considered abnormal, 174 (11.6%) suspicious and 1272 (84.9%) normal. 
 
Visual Fields 
Interpretation based on visual fields was not possible at baseline. A total of 508 
participants (glaucoma suspects and non-glaucoma suspects) were indicated for visual 
field testing at baseline of whom 342 (67.3%) completed the test on the Humphrey 
Visual Field Analyser. Of these, 63.2% and 69.1% of normal and glaucoma suspects had 
abnormal visual field results despite good reliability indices. These baseline results 
were therefore discarded. 
At follow-up, 1,309 (60.3%) participants successfully completed fields on the Henson 
8000 Field Analyser with reliable results. 1,074 (82.0%) were normal in both eyes, 122 
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(9.3%) had one or both eyes with suspicious fields and 113 (8.6%) had an abnormal 
field in one or both eyes.  
Based on gradable optic disc images at follow-up in those with normal visual fields, the 
97.5th and 99.5th percentile VCDRs were 0.7 and 0.8 respectively (Figure 1).  
 
Signs of glaucoma 
At follow-up, 1,246 individuals had a VF measurement and a disc grading. Of these, 
895 (71.8%) had both a normal VF and a normal disc, 141 (11.3%) had a normal VF 
and suspicious or abnormal disc, 182 (14.6%) had a suspicious or abnormal VF and 
normal discs and 28 (2.2%) had both suspicious or abnormal VFs and suspicious or 
abnormal discs.  
Using the ISGEO classification 88 participants were considered to have glaucoma 
based on meeting either the ISGEO 1 (n= 64), 2 (n=22) or 3 (n=2) criteria, 1,973 
participants did not meet ISGEO criteria and were deemed non-glaucoma, 110 could 
not be classified (Figure 2).  
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Based on follow up optic disc grading from images, visual fields, IOP and visual acuity, 
participants were defined as glaucoma positive or negative based on the ISGEO 
criteria.  Vision status comparing participants with and without ISGEO glaucoma are 
described in Table 5 showing participants with glaucoma were more likely to have 
visual impairment. 85.2% of the non-glaucoma group classified as normal vision, 
compared to 72.7% in the glaucoma group. Blindness and VI were more prevalent in 
the glaucoma group, 5.7% and 21.6% respectively compared to those without 
glaucoma, 1.2% and 13.6% respectively.  
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Baseline and follow-up risk analyses was conducted and is summarised in Table 6. 
There was some evidence of an association of glaucoma with gender (male as baseline, 
Female OR=0.69, 95%CI: 0.45-1.06, p=0.10). No evidence of an association was found 
between baseline IOP and BMI (p=0.49), height (p=0.58) and weight (p=0.28). 
Associations of glaucoma with ophthalmic signs at follow-up were seen for both IOP 
(IOP>21mmHG OR: 4.10 (95%CI, 2.08-8.08), p<0.001) and a relative afferent 
pupillary defect (RAPD) showing a particularly strong association with being 
categorised as glaucoma (Confirmed RAPD OR: 7.39 (4.20-13.01), p<0.001).  
 
 
 
Discussion 
In this study we have described the population distributions and normative ranges 
from an epidemiological survey of glaucoma in an East African population in Kenya. 
Structural damage manifest by optic nerve changes was comparable in terms of the 
population distribution to other studies (described below). In those with glaucoma at 
follow-up, the strongest predictors were the presence at follow-up of an RAPD and 
IOP above 21mmHg. No demographic or anthropometric risk factors were associated 
with glaucoma.  
The prevalence of glaucoma on those followed up was 4.3% (CI, 3.5-5.9) which is 
comparable to other population based studies in Africa which range from 4.2% (3.5-
4.9) to 7.3% (5.5-9.1)25, 26 with a higher prevalence in west African populations (Nigeria 
5.0% (4.6-5.5) and 7.3% (5.5-9.1),26 Ghana 6.5% (5.8-7.1)27) than is East and Southern 
African populations (Tanzania 4.2% (3.5-4.9),25 South Africa 4.5% (3.2-6.1)28 and 5.3% 
(3.9-7.1)29). 
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The basis of the diagnosis of glaucoma in the majority of cases, both in clinical settings 
and in population based surveys, is correlation of structural optic nerve damage and 
loss of function demonstrated by visual field testing.30 However, in SSA, where 
equipment constraints are considerable,31 visual field testing is not widely available. A 
survey in Lagos State, Nigeria identified one visual field analyser for every 2,380,000 
population including private and governmental facilities. 32 Even where field analysers 
are available, they are of much less importance in the diagnosis and treatment decision 
making process than in more resource intense settings; visual field changes were a 
factor in only 4% of treatment decisions in a review of 344 patients attending a 
glaucoma clinic in South African.33 Population based studies have demonstrated that 
there are substantial difficulties in achieving adequate field testing in SSA populations.34 
The lack of a reliable visual field in the baseline of this cohort is consistent with other 
studies in the region that have faced similar challenges such as the Nigerian National 
Blindness Survey that used a relatively simple testing modality, the Humphrey 
Frequency Doubling Technology test, where adequate testing was only available for 
60% of 4,538 Nigerian patients.34 Furthermore, the logistical problems obtaining 
reliable visual field tests mean that they were not included in the flow chart for 
community diagnosis of glaucoma in a recently published West African algorithm; 
relative afferent pupillary defect testing was the chosen test of nerve function,35 which 
the findings of this study concur with. 
  
Diagnosis and management of glaucoma in SSA, therefore, centres very much around 
IOP and optic nerve assessment, the latter through direct visualisation and pupil 
assessment. Very little data from longitudinal population-based cohorts exist, with 
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none to date from SSA, on glaucoma. This cohort study of people aged 50+ 
undertaken in Nakuru, Kenya, with baseline in 2007-8 and follow-up in 2013-14 was 
an opportunity to estimate the normative range of various features of glaucoma as 
well as potential features that are important for clinical decision making in a context 
where availability of equipment is limited.  
The percentile distributions of optic nerve VCDR and IOP in the Nakuru Cohort 
follow-up subgroup in whom image grading was available was very similar to the 
Nigeria National Blindness survey, a nationally representative survey of adults 40 years 
and older, which is to our knowledge the only National survey in SSA to derive 
percentile values for defining glaucoma in population-based surveys.36  At the 97.5th 
and 99.5th percentiles the VCDR in Kenya was 0.7 and 0.8 respectively and 0.75 and 
0.95 in Nigeria (in all the population with gradable disc images). The median VCDR 
was lower in Kenya at 0.23 compared to 0.4 in Nigeria.36 Our findings are also 
consistent with other population-based studies in the region where a VCDR of 0.7 
was consistent at the 97.5th percentile however greater variation is found at the 99.5th 
from 0.7 in Tanzania to 0.9 in South Africa. 27, 29, 37, 38 
The IOP distribution in Kenya was similar at baseline and follow-up with a higher 
median than in Nigeria (15 vs. 14mmHg) but lower IOP at the 97.5th and 99.5th 
percentiles (Kenya: 22, 27mmHg vs. Nigeria: 24, 34mmHg).36  
 
Changes over the period of the cohort were difficult to define conclusively due to the 
clinical nature of a glaucoma diagnosis, however a strong association between optic 
discs and visual fields considered to be outside of normal range was demonstrated, in 
particular with the relative afferent pupil defect (RAPD) test. An IOP over 21mmHg 
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was also less strongly associated with glaucoma as defined by the ISGEO criteria in 
this study. The findings suggest a combination of optic nerve assessment by both 
visualisation including VCDR grading as well assessing function through the RAPD test 
are practical means for identifying individuals who have or are at risk of sight loss from 
glaucoma. Portable tools for assessing vision 39 and optic disc imaging 40 may make this 
more accessible with IOP being a suitable method to monitor an effect from treatment 
and various handheld tools now available for accurate IOP assessment independent of 
a slit lamp.  
Management of glaucoma remains a major challenge in SSA with limited availability and 
poor adherence to medical treatment when available. A primary surgical approach has 
problems also, in that patients presenting due to visual loss in one eye need to be 
persuaded to undergo surgery, most frequently with direct financial costs to them, in 
the other eye which they do not as yet consider to have a problem. 11, 41 The operation 
of choice, trabeculectomy augmented by anti-metabolites, does not improve the vision 
in most cases, but in fact can lead to visual acuity reduction. Identification of new 
treatment options in Africa therefore remains a priority. 
 
Strengths of this study included it being a large, population-based sample, 
representative of a population on which there is minimal data. A senior 
ophthalmologist examined all study participants at baseline and follow up. High quality, 
modern, equipment was used throughout.  
Limitations included a high loss to follow up (50%) at six years, this was primarily due 
to post-election violence affecting the study population with large numbers of people 
displaced or killed. Major variations in baseline and follow-up data collection protocols 
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were employed, in part due to challenges at baseline such as unreliable visual field 
data, retinal camera break down and due to a lack of availability of all baseline 
equipment at follow-up, e.g. no repeat AC-OCT was undertaken. Key measurement 
differences and therefore potential measurement bias were i) likely with visual fields 
at baseline being completed for glaucoma suspects (n=165) and a sub-set of normal 
participants (n=343) (11.6% of all baseline participants) only and using a Humphrey 
field analyser with outputs that could not be confidently used to make an assessment 
of glaucoma, the Henson 8000 was used at follow-up, ii) anterior chamber angle 
assessment at baseline was based on AC-OCT and on 4-mirror gonioscopy at follow-
up, iv) a statistically significant variation between right and left eye IOP at baseline and 
follow up. IOP was on average higher in the right than the left eye at both baseline 
and follow-up. This may have arisen because the right eye was tested first and/or 
because the majority of the population was assumed to be right-handed, and IOP 
measurement is associated with hand dominance. 42, 43  
  
In conclusion, glaucoma remains a public health concern. However, the lack of cost-
effective treatments and challenges identifying high-risk individuals means that 
population-based screening for open-angle glaucoma should not currently be 
recommended.44 Further research in to the risk factors, natural history and aetiology 
of glaucoma in Africa and the barriers to effective sight loss prevention are required.  
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Figure and Table Legends 
 
Table 1. OCT Summary of normative findings of the anterior segment at baseline (in 
those without glaucoma) 
 
 
Table 2. Gonioscopic grading of the angle in the follow-up of the Nakuru Eye 
Disease Cohort Study 
 
 
Table 3. Intraocular Pressure in the Nakuru Eye Disease Cohort 
 
Table 4. Baseline clinical (undilated and dilated) optic disc assessment made at the slit 
lamp  
 
Table 5 . Visual status of participants at follow-up with and without glaucoma  
 
Table 6. Association of anthropometric risk factors at baseline and ophthalmic risk 
factors at follow-up with glaucoma at follow-up (*follow-up risk factor) 
 
Figure 1. The distribution of VCDRs at follow up from retinal images 
 
Figure 2. The ISGEO Classification of the Nakuru Eye Disease Cohort follow-up group 
